Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma

Jia XuEye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, People’s Republic of ChinaView further author information

Yinu ZhaoEye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, People’s Republic of ChinaView further author information

Hongjing SunEye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, People’s Republic of ChinaView further author information

Qing XiaoEye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, People’s Republic of ChinaView further author information

Panpan YeEye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date